1,146
Participants
Start Date
May 30, 2024
Primary Completion Date
October 30, 2025
Study Completion Date
December 31, 2025
Medication plan review
Intervention group patients will receive a revised medication plan by external pharmacologist based on the the STOPP/START criteria. The revised medication plan will be provided to the family physician who then will provide it to the patient. The revision comes along with evidence based information for the physician to prevent possible uncertainties by the physicians.
Adherence support
Intervention group patients will receive a study nurse administered adherence support measure based on telephone-based motivational interviewing. The measure includes information on possible consequences of inadherence and signs of adverse drug reactions that is comprehensible for lay persons.
RECRUITING
HAP ANZ, Halle
University of Leipzig
OTHER
Hannover Medical School
OTHER
Martin-Luther-Universität Halle-Wittenberg
OTHER